価格表

在庫・価格 : 2025年05月01日 12時26分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Prealbumin, Human, ELISA Kit, AssayMax (96 well)
EP3010-1 ANGアッセイプロ
AssayPro
1 kit ¥77,000
(未発注)
追加

在庫・価格 : 2025年05月01日 12時26分 現在

Prealbumin, Human, ELISA Kit, AssayMax (96 well)

  • 商品コード:EP3010-1
  • メーカー:ANG
  • 包装:1kit
  • 価格: ¥77,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Escher N et al. (2007) Posttranslational Modifications of Transthyretin Are Serum Markers in Patients with Mycosis Fungoides1. Neoplasia. 9(3): 254-259

PubMed
2 Maheshwari A et al. (2009) Developmental changes in circulating IL-8/CXCL8 isoforms in neonates. Cytokine. 46(1):12-16

PubMed
3 Wang FE et al (2010) MicroRNA-204/211 alters epithelial physiology. FASEB J. 24(5):1552-1571

PubMed
4 Alvarez R et al. (2011) Sirna therapy for transthyretin (ttr) related ocular amyloidosis. Patent application: CA 2792291 A1

PubMed
5 Mastricci AL et al. (2011) Are Serum Protein Biomarkers Derived from Proteomic Analysis Useful in Screening for Trisomy 21 at 11・3 Weeks? Fetal Diagn Ther. 30(1):53-59

PubMed
6 Perrin RJ et al. (2011) Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease. PloSOne Jan 12; 6(1):e16032

PubMed
7 Sah D (2011) Lipid formulated compositions and methods for inhibiting expression of transthyretin (TTR). WIPO Patent Application US2010/055311

PubMed
8 Wang F and Miller S (2011) Mir 204, mir 211, their anti-mirs, and therapeutic uses of same. USPTO Patent Applicaton 20110190378

PubMed
9 Alvarez R et al. (2012) Compositions and methods for inhibiting expression of transthyretin. Patent number: US8168775 B2

PubMed
10 Velayudhan L et al. (2012) Plasma Transthyretin as a Candidate Marker for Alzheimer逞エ Disease.PLoS One. 7(6):e38703. doi: 10.1371/journal.pone.0038703. Epub 2012 Jun 7

PubMed
11 Kallanthottathil R et al. (2013) RNAI AGENTS, COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING TRANSTHYRETIN (TTR) ASSOCIATED DISEASES. WIPO Patent Application WO/2013/075035. Patent Application number: US2012/065691

PubMed
12 Tsui H (2014) Neuropsychological and plasma biomarkers for detecting Alzheimer's disease. Brain Health Research Center.

PubMed
13 Zhu L et al. (2014) Transthyretin as a novel candidate biomarker for preeclampsia. Exp Ther Med.7(5):1332-1336. Epub 2014 Feb 18

PubMed
14 Pasella S (2015) Plasma concentrations of transthyretin in older Sardinians including centenarians. Aging Clin Exp Res. 2015 May 21

PubMed
  • No.: 1
  • 文献情報:
    Escher N et al. (2007) Posttranslational Modifications of Transthyretin Are Serum Markers in Patients with Mycosis Fungoides1. Neoplasia. 9(3): 254-259

  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Maheshwari A et al. (2009) Developmental changes in circulating IL-8/CXCL8 isoforms in neonates. Cytokine. 46(1):12-16

  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Wang FE et al (2010) MicroRNA-204/211 alters epithelial physiology. FASEB J. 24(5):1552-1571

  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Alvarez R et al. (2011) Sirna therapy for transthyretin (ttr) related ocular amyloidosis. Patent application: CA 2792291 A1

  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Mastricci AL et al. (2011) Are Serum Protein Biomarkers Derived from Proteomic Analysis Useful in Screening for Trisomy 21 at 11・3 Weeks? Fetal Diagn Ther. 30(1):53-59

  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Perrin RJ et al. (2011) Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease. PloSOne Jan 12; 6(1):e16032

  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Sah D (2011) Lipid formulated compositions and methods for inhibiting expression of transthyretin (TTR). WIPO Patent Application US2010/055311

  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Wang F and Miller S (2011) Mir 204, mir 211, their anti-mirs, and therapeutic uses of same. USPTO Patent Applicaton 20110190378

  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Alvarez R et al. (2012) Compositions and methods for inhibiting expression of transthyretin. Patent number: US8168775 B2

  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Velayudhan L et al. (2012) Plasma Transthyretin as a Candidate Marker for Alzheimer逞エ Disease.PLoS One. 7(6):e38703. doi: 10.1371/journal.pone.0038703. Epub 2012 Jun 7

  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Kallanthottathil R et al. (2013) RNAI AGENTS, COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING TRANSTHYRETIN (TTR) ASSOCIATED DISEASES. WIPO Patent Application WO/2013/075035. Patent Application number: US2012/065691

  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Tsui H (2014) Neuropsychological and plasma biomarkers for detecting Alzheimer's disease. Brain Health Research Center.

  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Zhu L et al. (2014) Transthyretin as a novel candidate biomarker for preeclampsia. Exp Ther Med.7(5):1332-1336. Epub 2014 Feb 18

  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Pasella S (2015) Plasma concentrations of transthyretin in older Sardinians including centenarians. Aging Clin Exp Res. 2015 May 21

  • 備考:
  • 参照:
    PubMed